Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy

Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy

imedex

10 months
411 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME credit for this activity: https://www.naccme.com/program/2018-802-03

This on-demand activity examines the implications of BRCA mutational status, BRCAness, synthetic lethality, and within-class differences in the mechanisms of action, efficacy and safety, and indications of available and emerging PARP inhibitors for optimal ovarian cancer pathway integration.

© 2018 NACCME, an HMP Company
Up Next Autoplay
Phase I/II Study of Ruxolitinib @SeattleCCA @heidigraydrezn5 @UWashOBGYN
Phase I/II Study of Ruxolitinib @SeattleCCA @heidigraydrezn5 @UWashOBGYN
Category: Ovarian Cancer
27 Views
SeattleCCA 2 months
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
24 Views
Cancer-News 3 months
New Frontier Possibility for Preventing Ovarian Cancer
New Frontier Possibility for Preventing Ovarian Cancer
Category: Ovarian Cancer
10 Views
Cancer-News 3 months
"Wild idea" opens possible new boundaries to ovarian cancer prevention
Category: Ovarian Cancer
12 Views
Cancer-News 3 months
Study Finds IUD Use Decreased Risk Of Ovarian Cancer By As Much As 32 Percent
Study Finds IUD Use Decreased Risk Of Ovarian Cancer By As Much As 32 Percent
Category: Ovarian Cancer
11 Views
Cancer-News 4 months
PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication Management
PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication Management
Category: Ovarian Cancer
128 Views
imedex 9 months
The importance of encouraging patients to talk about symptoms
The importance of encouraging patients to talk about symptoms
Category: Ovarian Cancer
102 Views
VJOncology 1 year
Quality of life can impact PFS in ovarian cancer
Quality of life can impact PFS in ovarian cancer
Category: Ovarian Cancer
79 Views
VJOncology 1 year
Management of immunotherapy toxicity in gynecological cancers
Management of immunotherapy toxicity in gynecological cancers
Category: Ovarian Cancer
523 Views
VJOncology 1 year